Class information for:
Level 1: 5 HT2C RECEPTOR//5 HT2A RECEPTOR//5 HT2C

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
3578 1954 48.8 76%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
11 4 NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL 1112395
76 3       NEUROSCIENCES//DOPAMINE//SEROTONIN 81359
218 2             SEROTONIN//5 HT1A RECEPTOR//5 HT2A RECEPTOR 20633
3578 1                   5 HT2C RECEPTOR//5 HT2A RECEPTOR//5 HT2C 1954

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 5 HT2C RECEPTOR authKW 1216123 8% 48% 161
2 5 HT2A RECEPTOR authKW 520632 8% 22% 151
3 5 HT2C authKW 370374 3% 44% 54
4 HALLUCINOGENS authKW 357149 5% 23% 98
5 RO 60 0175 authKW 290318 1% 77% 24
6 SB 242084 authKW 285651 1% 63% 29
7 DOI authKW 276449 4% 26% 69
8 5 HT2 RECEPTOR authKW 182213 4% 16% 71
9 DRUG INDUCED STIMULUS CONTROL authKW 161180 1% 74% 14
10 LYSERGIC ACID DIETHYLAMIDE LSD authKW 137920 1% 55% 16

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Pharmacology & Pharmacy 19297 57% 0% 1123
2 Neurosciences 15906 52% 0% 1021
3 Behavioral Sciences 3600 10% 0% 196
4 Psychiatry 3495 16% 0% 313
5 Chemistry, Medicinal 2127 10% 0% 203
6 Biochemistry & Molecular Biology 55 9% 0% 185
7 Chemistry, Organic 34 4% 0% 72
8 Medicine, Research & Experimental 28 3% 0% 52
9 Clinical Neurology 21 3% 0% 61
10 Substance Abuse 11 1% 0% 11

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PHYSIOPATHOL ADDICT GRP 70311 0% 75% 6
2 SEROTONIN DISORDERS 47610 0% 38% 8
3 SECT BIOPSYCHOL 40161 1% 21% 12
4 IST FISIOL UMANA G PAGANO 31251 0% 100% 2
5 JUPITER LIFE SCI INITIAT 31251 0% 100% 2
6 LIFE SCI INITIAT 31251 0% 100% 2
7 WG DEWHURST 31247 0% 50% 4
8 UMR 5541 18160 1% 11% 11
9 CHEM BIOL BRANCH 15884 1% 8% 13
10 1E7 44 WMHSC 15625 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 PSYCHOPHARMACOLOGY 32217 8% 1% 158
2 PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR 19887 6% 1% 126
3 NEUROPHARMACOLOGY 19734 6% 1% 109
4 JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 10565 6% 1% 120
5 NEUROPSYCHOPHARMACOLOGY 9246 3% 1% 55
6 EUROPEAN JOURNAL OF PHARMACOLOGY 8422 6% 0% 124
7 MOLECULAR PHARMACOLOGY 4943 3% 1% 56
8 JOURNAL OF MEDICINAL CHEMISTRY 3171 3% 0% 67
9 BEHAVIOURAL PHARMACOLOGY 2298 1% 1% 17
10 INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY 2241 1% 1% 16

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 5 HT2C RECEPTOR 1216123 8% 48% 161 Search 5+HT2C+RECEPTOR Search 5+HT2C+RECEPTOR
2 5 HT2A RECEPTOR 520632 8% 22% 151 Search 5+HT2A+RECEPTOR Search 5+HT2A+RECEPTOR
3 5 HT2C 370374 3% 44% 54 Search 5+HT2C Search 5+HT2C
4 HALLUCINOGENS 357149 5% 23% 98 Search HALLUCINOGENS Search HALLUCINOGENS
5 RO 60 0175 290318 1% 77% 24 Search RO+60+0175 Search RO+60+0175
6 SB 242084 285651 1% 63% 29 Search SB+242084 Search SB+242084
7 DOI 276449 4% 26% 69 Search DOI Search DOI
8 5 HT2 RECEPTOR 182213 4% 16% 71 Search 5+HT2+RECEPTOR Search 5+HT2+RECEPTOR
9 DRUG INDUCED STIMULUS CONTROL 161180 1% 74% 14 Search DRUG+INDUCED+STIMULUS+CONTROL Search DRUG+INDUCED+STIMULUS+CONTROL
10 LYSERGIC ACID DIETHYLAMIDE LSD 137920 1% 55% 16 Search LYSERGIC+ACID+DIETHYLAMIDE+LSD Search LYSERGIC+ACID+DIETHYLAMIDE+LSD

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 DI GIOVANNI, G , DE DEURVVAERDERE, P , (2016) NEW THERAPEUTIC OPPORTUNITIES FOR 5-HT2C RECEPTOR LIGANDS IN NEUROPSYCHIATRIC DISORDERS.PHARMACOLOGY & THERAPEUTICS. VOL. 157. ISSUE . P. 125 -162 242 42% 5
2 NICHOLS, DE , (2016) PSYCHEDELICS.PHARMACOLOGICAL REVIEWS. VOL. 68. ISSUE 2. P. 264 -355 175 35% 13
3 NICHOLS, DE , (2004) HALLUCINOGENS.PHARMACOLOGY & THERAPEUTICS. VOL. 101. ISSUE 2. P. 131-181 172 51% 427
4 CANAL, CE , MORGAN, D , (2012) HEAD-TWITCH RESPONSE IN RODENTS INDUCED BY THE HALLUCINOGEN 2,5-DIMETHOXY-4-IODOAMPHETAMINE: A COMPREHENSIVE HISTORY, A RE-EVALUATION OF MECHANISMS, AND ITS UTILITY AS A MODEL.DRUG TESTING AND ANALYSIS. VOL. 4. ISSUE 7-8. P. 556 -576 145 62% 40
5 HALBERSTADT, AL , (2015) RECENT ADVANCES IN THE NEUROPSYCHOPHARMACOLOGY OF SEROTONERGIC HALLUCINOGENS.BEHAVIOURAL BRAIN RESEARCH. VOL. 277. ISSUE . P. 99 -120 153 44% 25
6 FILIP, M , SPAMPINATO, U , MCCREARY, AC , PRZEGALINSKI, E , (2012) PHARMACOLOGICAL AND GENETIC INTERVENTIONS IN SEROTONIN (5-HT)(2C) RECEPTORS TO ALTER DRUG ABUSE AND DEPENDENCE PROCESSES.BRAIN RESEARCH. VOL. 1476. ISSUE . P. 132 -153 112 71% 10
7 HOWELL, LL , CUNNINGHAM, KA , (2015) SEROTONIN 5-HT2 RECEPTOR INTERACTIONS WITH DOPAMINE FUNCTION: IMPLICATIONS FOR THERAPEUTICS IN COCAINE USE DISORDER.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 1. P. 176 -197 116 43% 26
8 DI GIOVANNI, G , DI MATTEO, V , PLERUCCI, M , BENIGNO, A , ESPOSITO, E , (2006) CENTRAL SEROTONIN(2C) RECEPTOR: FROM PHYSIOLOGY TO PATHOLOGY.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 6. ISSUE 18. P. 1909-1925 124 61% 42
9 HALBERSTADT, AL , GEYER, MA , (2011) MULTIPLE RECEPTORS CONTRIBUTE TO THE BEHAVIORAL EFFECTS OF INDOLEAMINE HALLUCINOGENS.NEUROPHARMACOLOGY. VOL. 61. ISSUE 3. P. 364 -381 111 52% 45
10 BUBAR, MJ , CUNNINGHAM, KA , (2008) PROSPECTS FOR SEROTONIN 5-HT2R PHARMACOTHERAPY IN PSYCHOSTIMULANT ABUSE.SEROTONIN-DOPAMINE INTERACTION: EXPERIMENTAL EVIDENCE AND THERAPEUTIC RELEVANCE. VOL. 172. ISSUE . P. 319-346 110 49% 65

Classes with closest relation at Level 1


Rank Class id link
1 11921 5 HT1B RECEPTOR//5 HT MODULINE//UNITE PHARMACOL NEUROIMMUNOENDOCRINIENNE
2 13693 AYAHUASCA//PSILOCYBIN//PSYCHEDELICS
3 3624 5 HT1A RECEPTOR//BUSPIRONE//8 OH DPAT
4 10808 D FENFLURAMINE//FENFLURAMINE//PROLACTIN
5 11145 5 HT7 RECEPTOR//5 HT6 RECEPTOR//5 HT6
6 7952 PINDOLOL//VILAZODONE//5 HT1A RECEPTOR
7 3791 SARPOGRELATE//5 HT1 LIKE RECEPTORS//KETANSERIN
8 10822 AMPEROZIDE//CLOZAPINE//SAVOXEPINE
9 7634 SEROTONIN TRANSPORTER//C 11DASB//I 123 ADAM
10 6263 DEXFENFLURAMINE//D FENFLURAMINE//FENFLURAMINE

Go to start page